These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36368316)

  • 21. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
    Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
    Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression.
    Wang J; Qin X; Sun H; He M; Lv Q; Gao C; He X; Liao H
    Aging Cell; 2021 Dec; 20(12):e13515. PubMed ID: 34821024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
    Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
    Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease.
    Rodríguez JJ; Witton J; Olabarria M; Noristani HN; Verkhratsky A
    Cell Death Dis; 2010; 1(1):e1. PubMed ID: 21364611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhao R; Hu W; Tsai J; Li W; Gan WB
    Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in
    Shin JH; Hwang YS; Jung BK; Seo SH; Ham DW; Shin EH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology.
    Krabbe G; Halle A; Matyash V; Rinnenthal JL; Eom GD; Bernhardt U; Miller KR; Prokop S; Kettenmann H; Heppner FL
    PLoS One; 2013; 8(4):e60921. PubMed ID: 23577177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection Augments Expression of Mechanosensing Piezo1 Channels in Amyloid Plaque-Reactive Astrocytes.
    Velasco-Estevez M; Mampay M; Boutin H; Chaney A; Warn P; Sharp A; Burgess E; Moeendarbary E; Dev KK; Sheridan GK
    Front Aging Neurosci; 2018; 10():332. PubMed ID: 30405400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model.
    Wickline JL; Smith S; Shin R; Odfalk K; Sanchez J; Javors M; Ginsburg B; Hopp SC
    Neuropharmacology; 2023 Apr; 227():109454. PubMed ID: 36740015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial Piezo1 mechanosensitive channel as a therapeutic target in Alzheimer's disease.
    Ikiz ED; Hascup ER; Bae C; Hascup KN
    Front Cell Neurosci; 2024; 18():1423410. PubMed ID: 38957539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.
    Fruhwürth S; Zetterberg H; Paludan SR
    J Neuroimmunol; 2024 May; 390():578342. PubMed ID: 38640827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.